| 000 | 01491 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514183822.0 | ||
| 264 | 0 | _c20040415 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0025-6196 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShifren, Jan L | |
| 245 | 0 | 0 |
_aThe role of androgens in female sexual dysfunction. _h[electronic resource] |
| 260 |
_bMayo Clinic proceedings _cApr 2004 |
||
| 300 |
_aS19-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAndrogens _xchemistry |
| 650 | 0 | 4 |
_aArousal _xdrug effects |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDehydroepiandrosterone _xchemistry |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 |
_aHormone Replacement Therapy _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aLibido _xdrug effects |
| 650 | 0 | 4 |
_aMenopause _xdrug effects |
| 650 | 0 | 4 |
_aMethyltestosterone _xchemistry |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPremenopause _xdrug effects |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSex Counseling |
| 650 | 0 | 4 |
_aSexual Dysfunctions, Psychological _xetiology |
| 650 | 0 | 4 |
_aTestosterone _xchemistry |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tMayo Clinic proceedings _gvol. 79 _gno. 4 Suppl _gp. S19-24 |
|
| 999 |
_c14781220 _d14781220 |
||